Author

Ilia Tikhonov 1

1 Janssen Research & Development, LLC,Spring House,United States

Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Bruce E. Sands, William Sandborn, Remo Panaccione, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, Yiying Zhou, Ilia Tikhonov, Laurent Peyrin-Biroulet, Gert Van Assche, Silvio Danese, Stephan Targan, Maria T. Abreu, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, David Rowbotham, Ramesh P. Arasaradnam, Colleen W.

SAFETY OF USTEKINUMAB ACROSS APPROVED ADULT INDICATIONS: POOLED SAFETY ANALYSIS IN CROHN’S DISEASE, ULCERATIVE COLITIS, PSORIASIS, AND PSORIATIC ARTHRITIS THROUGH UP TO 5 YEARS

Silvio Danese, Millie Long, Elyssa Ott, Christopher Gasink, Thomas Baker, Ye Miao, Ilia Tikhonov, Proton Rahman, Edward V. Loftus, Bruce Strober

Safety of Ustekinumab in Inflammatory Bowel Diseases: Integrated Safety Analysis of Results from Phase 2 and 3 Studies in Crohn's Disease and Ulcerative Colitis

Subrata Ghosh, Bruce E. Sands, Christopher D. O'Brien, Ilia Tikhonov, Yiying Zhou, Sheri Volger, Colleen W. Marano, Elyssa Ott, Christopher Gasink, William Sandborn, Silvio Danese

Item 1 - 3 / 3
1